Patient needs in advanced Renal Cell Carcinoma: What are patients’ priorities and how well are we meeting them?

Treatment options and duration of therapy for patients with metastatic renal cell carcinoma (mRCC) have increased. Many patients now spend in excess of 2 years on active therapy. These patients’ needs, and the ability of health services to respond to them, are poorly understood. Ten patients living...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rick Harris, Kate Oake, Robert Hawkins, Robert Jones, Thomas Powles, David Montgomery
Formato: article
Lenguaje:EN
Publicado: The Beryl Institute 2015
Materias:
ipa
Acceso en línea:https://doaj.org/article/86c07aa0dc4446b4bad3b04f662880d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!